Ridiculous78 Posted - 11 hours ago

@johnsmith31 @Russell007xx 4) ARDS data was huge. Significant decrease of bacteria in all organs IN VIVO. Their iMSC had prevented the onset of ARDS and improved lung function in all lamb models. I have not ever seen data like that before personally. As for the pipeline, I think we will see the company try to expand out into as many partnered trials as they possibly can. I know for a fact they chose Sickle Cell because of the recent approval of the first cell-therapy by CRSP. I’m guessing they chose MS because of the ability of their iMSCs to reduce inflammation. Not sure why they chose ovarian, TNBC for cancer indications. They are a one in a kind niche — no other company has really expanded into mRNA targeted cell-engineering. Sure, there are companies like $FATE $CRSP $LCTX doing cell engineering, but not with the use of mRNA to exhibit certain proteins or gene-editing. Extremely exciting to be at the forefront of this as a retail investor.

flytrader1 Posted - 16 hours ago

$FATE when will this bottom?...

Agghh Posted - 22 hours ago

$FATE Could use a breather. Maybe a bounce off 200MA? StochRSI has been 0/0 for 6 days, not a single green candle in 10 days. Might be a swing candidate.

cekici1972 Posted - 1 day ago

$FATE

erevnon Posted - 2 days ago

Wedbush reiterates Fate Therapeutics $FATE at Neutral and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

PDM5 Posted - 2 days ago

$FATE Redmile added ANOTHER 4.5M shares, Boxer added 5.7M shares, Point72 added 1.5M shares, all top 5 holders. SMART money, be patient we'll be back....

Stock_Titan Posted - 3 days ago

$FATE Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting https://www.stocktitan.net/news/FATE/fate-therapeutics-announces-presentation-of-ft819-proof-of-concept-7sqkewfr9vak.html

theflynews Posted - 1 week ago

Fly Intel: After-Hours Movers - $FATE - https://thefly.com/permalinks/entry.php/FATEid3899503

DonCorleone77 Posted - 1 week ago

$FATE Fate Therapeutics files to sell 3.64M shares of common stock for holders

Sidd_F Posted - 1 week ago

@cninc I really think $FATE will be involved, but it's hard to say which of their products makes sense to pair w/ GT. I think they shelved the most likely ones.

Sidd_F Posted - 1 week ago

@cninc agree that a partnership is their best shot. I think $FATE is a dark horse candidate. Miller connection plus increasingly consensus view that NK cells need an engager to reach potential.

Noobnioo Posted - 1 week ago

$RIOT ADPT stock will be a bull. It's cheap now. 15% profit. $SPY $QQQ $VTYX $FATE 🍀

Aigner_Andreas Posted - 1 week ago

TD BUY $FATE at 5.77, Supp 5.77 Resis 7.34 R27 HiLo 61% T1Y 71 buy 1.8 DIV N/A #Fate Thera #stocks #trading #finance #market

nonewby Posted - 2 weeks ago

$FATE $ibrx not sure whats happening at FATE recently but if any are jumping ship to IBRX, welcome.

Shragez Posted - 2 weeks ago

$FATE Where is everybody?! Nobody on ST wants to know their fate??

nevermind889 Posted - 3 weeks ago

$ARQT $FATE $HOWL Fantastic day!

nevermind889 Posted - 3 weeks ago

$ARQT $FATE $HOWL These guys always find a way to do well!

Stock_Titan Posted - 3 weeks ago

$FATE Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/FATE/fate-therapeutics-to-present-at-23rd-annual-needham-virtual-e2ktiu5ot9v1.html

RallyRaider Posted - 03/31/24

$FATE guy says "we ve seen some really .... overwhelmingly positive benefit in patients that have lymphoma and multiple myeloma" like 15 seconds in

RallyRaider Posted - 03/31/24

$FATE Great journey here recently... Institutions scooping this up https://journey.ct.events/view/9df2116f-838c-4523-b23d-4c99f278e640 -------- kewl stuff!

WisoNYC Posted - 03/30/24

$FATE

erevnon Posted - 03/28/24

B of A Securities maintains Fate Therapeutics $FATE at Underperform and raises the price target from $2 to https://marketsblock.com/stock-upgrades-and-downgrades/

nevermind889 Posted - 03/28/24

$ARQT $FATE $XBI $LABU Strong day! nice!

nevermind889 Posted - 03/27/24

$HOWL $ARQT $FATE Great recovery day!

TragicTwits Posted - 4 weeks ago

@StMichaelTwits maybe it can pump like $FATE did.

LabPsycho Posted - 1 month ago

$FATE That they were 'only' able to get $100M in a private placement when many other depressed sub $3/share puny biotechs have been getting $100-$200M is not a good sign in my opinion

nevermind889 Posted - 1 month ago

$ARQT $FATE $APLT Strong day! Let's see a multi day rally! Thanks FOMC!

GreenRaccoon Posted - 1 month ago

$FATE

Texastradr Posted - 1 month ago

$FATE I honestly think this stock is extremely undervalued I see no reason it cant run to 16 dollars maybe I’m crazy

DonCorleone77 Posted - 1 month ago

$FATE Fate Therapeutics prices 14.5M shares at $5.50 in underwritten offering Fate Therapeutics announced the pricing of an underwritten offering of 14,545,454 shares of its common stock at an offering price of $5.50 per share. The offering includes participation from new and existing institutional investors, including Adage Capital Partners LP., Boxer Capital, Deep Track Capital, OrbiMed, Suvretta Capital and a life-sciences focused investor. In addition, the Company announced the pricing of a concurrent private placement of pre-funded warrants to purchase 3,636,364 shares of its common stock at a purchase price of $5.499 per pre-funded warrant, which represents the offering price per share of common stock less the $0.001 exercise price per share of each pre-funded warrant, to certain institutional and other accredited investors affiliated with or managed by Redmile Group. The gross proceeds from the underwritten offering and private placement are expected to be approx. $100MM...